Today, Shanghai Kaikai Industry Company Limited(600272) staged a “black minute” in the final stage of call auction: it fell 6.13% from the daily limit, with a cumulative decline of 14.68%.
According to the trading volume, turnover rate and dragon tiger list, Shanghai Kaikai Industry Company Limited(600272) and other big bull stocks that rose wildly in the early stage have entered the end of the game.
stage “black one minute”
As the first demon stock to double in 2022, Shanghai Kaikai Industry Company Limited(600272) staged almost the same story as yesterday most of the time today: opening high, opening high, walking fast, closing the trading limit, opening the trading limit, fully changing hands, and closing the trading limit again through the capital relay.
however, there was a startling reversal at the last minute of the call auction at the end of the day: a sale order with only 29800 hands directly hit Shanghai Kaikai Industry Company Limited(600272) from the daily limit to a decrease of 6.13%.
Many investors entered after opening the trading limit. Some shareholders in the stock bar said that they bought it after the opening of the board at noon. As a result, they lost 65000.
Source: Guba
Many other investors thought they would close at the daily limit. After entering the last call auction, they didn\’t stare at the market. As a result, when they opened it again, they shouted: “I\’ve fried stocks all my life. I\’ve seen people play like this in the last call auction for the first time.”
In fact, more than Shanghai Kaikai Industry Company Limited(600272) was “fried” at the end of today’s trading. Several stocks staged a sudden dive from the trading board: Kunming Longjin Pharmaceutical Co.Ltd(002750) , Beijing Cuiwei Tower Co.Ltd(603123) , Goody Science & Technology Co.Ltd(002694) all fell 6%, and the relatively small Aba Chemicals Corporation(300261) also fell more than 4%.
the game enters the “Bo silly” stage
today’s individual stocks of the collective fried board have one thing in common: they are all big bull stocks that rose wildly in the early stage. For example, Shanghai Kaikai Industry Company Limited(600272) has raised the daily limit for seven times this year, becoming the first stock to double since 2022.
With the rapid amplification of trading volume and the continuous rise of turnover rate, the game has entered the “Bo silly” stage, and the risk of changing the market is increasing. Take Shanghai Kaikai Industry Company Limited(600272) as an example. In the last six trading days, the turnover rate of Shanghai Kaikai Industry Company Limited(600272) has exceeded 20% and the turnover has exceeded 500 million yuan.
On the dragon and tiger list, institutions, hot money and retail investors launched a scuffle. Among them, on the Shanghai Kaikai Industry Company Limited(600272) dragon and tiger list on January 13, buy one, buy two, buy four, sell two and sell five seats are the base camp of retail investors, buy three is the special seat for institutions, and buy five, sell three and sell four seats are well-known hot money.
Shanghai Kaikai Industry Company Limited(600272) on January 12, a risk warning was issued that the company’s shares have been trading for eight consecutive trading days, the closing price has increased by 79.92%, the cumulative deviation from the Shanghai stock index is 80.5%, and the cumulative turnover rate is 116.34%. The company specially reminds investors to pay attention to stock investment risks, make prudent decisions, invest rationally, improve risk awareness and avoid blindly following the trend.
For the rumor that “the state secret formula of Liushen Pill of the company’s wholly-owned subsidiary Shanghai leiyunshang pharmaceutical West Co., Ltd.” is hot in the market, Shanghai Kaikai Industry Company Limited(600272) has also publicly clarified for many times that the company does not have any state secret pharmaceutical formula or Liushen Pill production business.
In addition, Shanghai Kaikai Industry Company Limited(600272) suggests that in recent years, the company’s pharmaceutical circulation business has been under pressure due to the impact of medical reform policies such as volume procurement; The company is actively seeking “great health” transformation, but the business transformation needs a long cultivation period, and the investment income is difficult to show in the short term. If the transformation project is gradually promoted, it may have a certain negative impact on the company’s profits at the beginning of the project.
